This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Centre National De La Recherche Scientifique. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: Pierre Milhiet: Innovator in Angiogenesis Inhibition
Introduction
Pierre Milhiet is a notable inventor based in Teyran, France. He has made significant contributions to the field of biotechnology, particularly in the area of angiogenesis inhibition. His work focuses on developing peptide fragments that can be utilized in therapeutic applications.
Latest Patents
Milhiet holds a patent for "Peptide fragments of the harp factor inhibiting angiogenesis." This invention concerns peptide fragments 13-39 and 65-97 of the HARP factor, which inhibit angiogenesis. Advantageously, these peptides can be associated with the peptide 111-136 of HARP. The invention also includes pharmaceutical compositions comprising these peptides or nucleic acids encoding them, and their use for treating pathologies associated with angiogenesis, particularly proliferative disorders such as cancer. He has 1 patent to his name.
Career Highlights
Pierre Milhiet is affiliated with the Centre National de la Recherche Scientifique, a prestigious research institution in France. His work at this institution has allowed him to explore innovative solutions in the medical field, particularly in cancer treatment.
Collaborations
Some of his notable coworkers include José Courty and Denis S Barritault. Their collaborative efforts have contributed to advancements in the understanding and treatment of diseases related to angiogenesis.
Conclusion
Pierre Milhiet's innovative work in peptide technology represents a significant advancement in the fight against cancer and other proliferative disorders. His contributions continue to inspire further research in the field of biotechnology.